Jakobsson, Jenny Kumlien, Christine
Identify and describe areas of concern focusing on day-to-day variations during the first month after surgery for patients recovering from colorectal cancer surgery. A multi-method design was applied using diaries and interviews. Data was collected using semi-structured diaries kept 1 month after surgery by seven patients recovering from colorectal...
Asayama, Naoki Yamane, Masahiro Kaneko, Mayumi Nagata, Shinji
Internal medicine (Tokyo, Japan)
Zhang, Lan Wang, Guan Zhu, Lingjuan Wei, Wei Zhang, Jin
Frontiers in Molecular Biosciences
Wang, Ren Lian, Jie Wang, Xin Pang, Xiangyi Xu, Benjie Tang, Shuli Shao, Jiayue Lu, Haibo
Frontiers in Oncology
Background This study aims to comprehensively summarize the colorectal survival rate in China. Method: In PubMed and Web of Science, keywords such as “colorectal cancer”, “survival” and “China” were used to search literatures in the past 10 years. Random effect models were selected to summarize 1-year, 3-year, and 5-year survival rates, and meta-re...
Yu, Lili Wang, Lijuan Sun, Jing Zhou, Xuan Hu, Yeting Hu, Lidan He, Yazhou Lin, Chunqing Chen, Jie Xu, Xiaolin
Frontiers in Genetics
N6-methyladenosine (m6A) modification has been demonstrated to exhibit a crucial prognostic effect on colorectal cancer (CRC). Nonetheless, potential mechanism of m6A in survival rate and immunotherapeutic response remains unknown. Here we investigated the genes associated with m6A regulators and developed a risk score for predicting the overall su...
Qu, Xiao Tan, Honghong Mao, Jingxian Yang, Mengxue Xu, Jian Yan, Xuebing Wu, Wenjuan
Colorectal cancer (CRC) is a commonly diagnosed human malignancy worldwide. Both epithelial-mesenchymal transition (EMT) and N6-methyladenosine (m6A) modification play a crucial role in CRC development. This study aimed to construct a prognostic signature based on the genes related to EMT and m6A modification. Firstly, the mRNA expression profiling...
Lee, Matthew H Pickhardt, Silas G Garrett, John W Perez, Alberto A Zea, Ryan Valle, Kevin Franco Lubner, Meghan G Bates, David D B Summers, Ronald M Pickhardt, Perry J
AJR. American journal of roentgenology
BACKGROUND. CT examinations contain opportunistic body composition data with potential prognostic utility. Previous studies have primarily used manual or semiautomated tools to evaluate body composition in patients with colorectal cancer (CRC). OBJECTIVE. The purpose of this article is to assess the utility of fully automated body composition measu...
Wang, Yan Wang, Wenling Dong, Hongming Wang, Gang Chen, Wanghua Chen, Juan Chen, Weiwei
Frontiers in Oncology
Background Fluoropyrimidine is an important component of systemic chemotherapy for colorectal cancer (CRC). Fluoropyrimidine-induced cardiotoxicity (FIC) may result in delay and discontinuation of chemotherapy and, in severe cases, can even be life-threatening. To date, risk factors for FIC have not been well identified. This cohort study aimed to ...
Tan, Li Peng, Dong Cheng, Yong
Journal of laparoendoscopic & advanced surgical techniques. Part A
Purpose: To figure out whether enhanced recovery after surgery (ERAS) could effectively improve the prognosis of colorectal cancer (CRC) patients and reduce hospitalization expenses under the shadow of COVID-19, furthermore to alleviate the current situation of medical resource for the whole society. Methods: Patients who underwent CRC surgery in t...
Zhang, Qi Luo, Hai Xun, Jing Ma, Yuan Yang, Lei Zhang, Lanqiu Wang, Ximo Yu, Xiangyang Wang, Botao
Whether proline deficiency is a metabolic vulnerability in colorectal tumors is unknown. The aim of this study was to investigate the effects of proline metabolism-related genes and exogenous proline on the progression of colorectal cancer (CRC). We aimed to further clarify the role of pyrroline-5-carboxylate reductase (PYCR) 2, a key enzyme of pro...